{"id":"https://openalex.org/W2604350448","doi":"https://doi.org/10.1200/jco.2004.22.14_suppl.4540","title":"Phase II trial of cisplatin (C), fixed-dose rate gemcitabine (G) and gefitinib for advanced transitional cell carcinoma (TCC) of the urothelial tract: Preliminary results of CALGB 90102","display_name":"Phase II trial of cisplatin (C), fixed-dose rate gemcitabine (G) and gefitinib for advanced transitional cell carcinoma (TCC) of the urothelial tract: Preliminary results of CALGB 90102","publication_year":2004,"publication_date":"2004-07-15","ids":{"openalex":"https://openalex.org/W2604350448","doi":"https://doi.org/10.1200/jco.2004.22.14_suppl.4540","mag":"2604350448"},"language":"en","primary_location":{"id":"doi:10.1200/jco.2004.22.14_suppl.4540","doi":"https://doi.org/10.1200/jco.2004.22.14_suppl.4540","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2004.22.14_suppl.4540","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5110813813","display_name":"George K. Philips","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I111236770","display_name":"University of Vermont","ror":"https://ror.org/0155zta11","country_code":"US","type":"education","lineage":["https://openalex.org/I111236770"]},{"id":"https://openalex.org/I1334819555","display_name":"Memorial Sloan Kettering Cancer Center","ror":"https://ror.org/02yrq0923","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334819555"]},{"id":"https://openalex.org/I180670191","display_name":"University of California, San Francisco","ror":"https://ror.org/043mz5j54","country_code":"US","type":"education","lineage":["https://openalex.org/I180670191"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"G. Philips","raw_affiliation_strings":["University of Vermont, Burlington, VT; CALGB Statistical Center, Durham, NC; Memorial Sloan-Kettering Cancer Center, New York, NY; University of California, San Francisco, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Vermont, Burlington, VT; CALGB Statistical Center, Durham, NC; Memorial Sloan-Kettering Cancer Center, New York, NY; University of California, San Francisco, CA","institution_ids":["https://openalex.org/I111236770","https://openalex.org/I1334819555","https://openalex.org/I180670191"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5053535513","display_name":"Susan Halabi","orcid":"https://orcid.org/0000-0003-4135-2777","observed_orcids":["https://orcid.org/0000-0003-4135-2777"]},"institutions":[{"id":"https://openalex.org/I111236770","display_name":"University of Vermont","ror":"https://ror.org/0155zta11","country_code":"US","type":"education","lineage":["https://openalex.org/I111236770"]},{"id":"https://openalex.org/I1334819555","display_name":"Memorial Sloan Kettering Cancer Center","ror":"https://ror.org/02yrq0923","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334819555"]},{"id":"https://openalex.org/I180670191","display_name":"University of California, San Francisco","ror":"https://ror.org/043mz5j54","country_code":"US","type":"education","lineage":["https://openalex.org/I180670191"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"S. Halabi","raw_affiliation_strings":["University of Vermont, Burlington, VT; CALGB Statistical Center, Durham, NC; Memorial Sloan-Kettering Cancer Center, New York, NY; University of California, San Francisco, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Vermont, Burlington, VT; CALGB Statistical Center, Durham, NC; Memorial Sloan-Kettering Cancer Center, New York, NY; University of California, San Francisco, CA","institution_ids":["https://openalex.org/I111236770","https://openalex.org/I1334819555","https://openalex.org/I180670191"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5054315990","display_name":"Ben L. Sanford","orcid":"https://orcid.org/0000-0003-2800-6319","observed_orcids":["https://orcid.org/0000-0003-2800-6319"]},"institutions":[{"id":"https://openalex.org/I111236770","display_name":"University of Vermont","ror":"https://ror.org/0155zta11","country_code":"US","type":"education","lineage":["https://openalex.org/I111236770"]},{"id":"https://openalex.org/I1334819555","display_name":"Memorial Sloan Kettering Cancer Center","ror":"https://ror.org/02yrq0923","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334819555"]},{"id":"https://openalex.org/I180670191","display_name":"University of California, San Francisco","ror":"https://ror.org/043mz5j54","country_code":"US","type":"education","lineage":["https://openalex.org/I180670191"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"B. Sanford","raw_affiliation_strings":["University of Vermont, Burlington, VT; CALGB Statistical Center, Durham, NC; Memorial Sloan-Kettering Cancer Center, New York, NY; University of California, San Francisco, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Vermont, Burlington, VT; CALGB Statistical Center, Durham, NC; Memorial Sloan-Kettering Cancer Center, New York, NY; University of California, San Francisco, CA","institution_ids":["https://openalex.org/I111236770","https://openalex.org/I1334819555","https://openalex.org/I180670191"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5064884168","display_name":"Dean F. Bajorin","orcid":"https://orcid.org/0000-0003-4001-7088","observed_orcids":["https://orcid.org/0000-0003-4001-7088"]},"institutions":[{"id":"https://openalex.org/I111236770","display_name":"University of Vermont","ror":"https://ror.org/0155zta11","country_code":"US","type":"education","lineage":["https://openalex.org/I111236770"]},{"id":"https://openalex.org/I1334819555","display_name":"Memorial Sloan Kettering Cancer Center","ror":"https://ror.org/02yrq0923","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334819555"]},{"id":"https://openalex.org/I180670191","display_name":"University of California, San Francisco","ror":"https://ror.org/043mz5j54","country_code":"US","type":"education","lineage":["https://openalex.org/I180670191"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"D. Bajorin","raw_affiliation_strings":["University of Vermont, Burlington, VT; CALGB Statistical Center, Durham, NC; Memorial Sloan-Kettering Cancer Center, New York, NY; University of California, San Francisco, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Vermont, Burlington, VT; CALGB Statistical Center, Durham, NC; Memorial Sloan-Kettering Cancer Center, New York, NY; University of California, San Francisco, CA","institution_ids":["https://openalex.org/I111236770","https://openalex.org/I1334819555","https://openalex.org/I180670191"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5007578304","display_name":"Eric Jay Small","orcid":"https://orcid.org/0000-0003-3191-6268","observed_orcids":["https://orcid.org/0000-0003-3191-6268"]},"institutions":[{"id":"https://openalex.org/I111236770","display_name":"University of Vermont","ror":"https://ror.org/0155zta11","country_code":"US","type":"education","lineage":["https://openalex.org/I111236770"]},{"id":"https://openalex.org/I1334819555","display_name":"Memorial Sloan Kettering Cancer Center","ror":"https://ror.org/02yrq0923","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334819555"]},{"id":"https://openalex.org/I180670191","display_name":"University of California, San Francisco","ror":"https://ror.org/043mz5j54","country_code":"US","type":"education","lineage":["https://openalex.org/I180670191"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"E. Small","raw_affiliation_strings":["University of Vermont, Burlington, VT; CALGB Statistical Center, Durham, NC; Memorial Sloan-Kettering Cancer Center, New York, NY; University of California, San Francisco, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Vermont, Burlington, VT; CALGB Statistical Center, Durham, NC; Memorial Sloan-Kettering Cancer Center, New York, NY; University of California, San Francisco, CA","institution_ids":["https://openalex.org/I111236770","https://openalex.org/I1334819555","https://openalex.org/I180670191"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":14,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"22","issue":"14_suppl","first_page":"4540","last_page":"4540"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10458","display_name":"Bladder and Urothelial Cancer Treatments","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2746","display_name":"Surgery"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10458","display_name":"Bladder and Urothelial Cancer Treatments","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2746","display_name":"Surgery"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10417","display_name":"Lung Cancer Treatments and Mutations","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10307","display_name":"Head and Neck Cancer Studies","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2733","display_name":"Otorhinolaryngology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/urothelial-carcinoma","display_name":"urothelial carcinoma","score":0.9430000185966492},{"id":"https://openalex.org/keywords/cisplatin","display_name":"cisplatin","score":0.9259999990463257},{"id":"https://openalex.org/keywords/gemcitabine","display_name":"gemcitabine","score":0.9739999771118164},{"id":"https://openalex.org/keywords/gefitinib","display_name":"gefitinib","score":0.8510000109672546},{"id":"https://openalex.org/keywords/fixed-dose-rate-infusion","display_name":"fixed dose rate infusion","score":0.7599999904632568},{"id":"https://openalex.org/keywords/egfr-inhibition","display_name":"EGFR inhibition","score":0.7099999785423279},{"id":"https://openalex.org/keywords/combination-chemotherapy","display_name":"combination chemotherapy","score":0.796999990940094},{"id":"https://openalex.org/keywords/dose-limiting-toxicity","display_name":"dose-limiting toxicity","score":0.9390000104904175},{"id":"https://openalex.org/keywords/neutropenic-infection","display_name":"neutropenic infection","score":0.7039999961853027},{"id":"https://openalex.org/keywords/objective-response-rate","display_name":"objective response rate","score":0.5879999995231628},{"id":"https://openalex.org/keywords/advanced-bladder-cancer","display_name":"advanced bladder cancer","score":0.6990000009536743},{"id":"https://openalex.org/keywords/maintenance-therapy","display_name":"maintenance therapy","score":0.6349999904632568},{"id":"https://openalex.org/keywords/time-to-progression","display_name":"time to progression","score":0.6230000257492065},{"id":"https://openalex.org/keywords/hyperuricemia","display_name":"hyperuricemia","score":0.6819999814033508},{"id":"https://openalex.org/keywords/diarrhea","display_name":"diarrhea","score":0.7260000109672546},{"id":"https://openalex.org/keywords/skin-rash","display_name":"rash","score":0.8299999833106995}],"concepts":[{"id":"https://openalex.org/C2780580887","wikidata":"https://www.wikidata.org/wiki/Q417824","display_name":"Gefitinib","level":4,"score":0.9237977862358093},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.892180323600769},{"id":"https://openalex.org/C2780258809","wikidata":"https://www.wikidata.org/wiki/Q414143","display_name":"Gemcitabine","level":3,"score":0.6898561716079712},{"id":"https://openalex.org/C2778570526","wikidata":"https://www.wikidata.org/wiki/Q653197","display_name":"Rash","level":2,"score":0.6896427273750305},{"id":"https://openalex.org/C2778496288","wikidata":"https://www.wikidata.org/wiki/Q6931269","display_name":"Mucositis","level":3,"score":0.62876296043396},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5580891966819763},{"id":"https://openalex.org/C2781413609","wikidata":"https://www.wikidata.org/wiki/Q7308373","display_name":"Regimen","level":2,"score":0.5112733840942383},{"id":"https://openalex.org/C126894567","wikidata":"https://www.wikidata.org/wiki/Q105650","display_name":"Urology","level":1,"score":0.48447608947753906},{"id":"https://openalex.org/C2780147359","wikidata":"https://www.wikidata.org/wiki/Q415869","display_name":"Carmustine","level":4,"score":0.418061763048172},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.4136376678943634},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.41090840101242065},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.35001665353775024},{"id":"https://openalex.org/C2779438470","wikidata":"https://www.wikidata.org/wiki/Q424401","display_name":"Epidermal growth factor receptor","level":3,"score":0.3133641481399536},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.26231080293655396},{"id":"https://openalex.org/C2778119113","wikidata":"https://www.wikidata.org/wiki/Q418817","display_name":"Etoposide","level":3,"score":0.0}],"mesh":[],"locations_count":2,"locations":[{"id":"doi:10.1200/jco.2004.22.14_suppl.4540","doi":"https://doi.org/10.1200/jco.2004.22.14_suppl.4540","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2004.22.14_suppl.4540","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},{"id":"doi:10.1200/jco.2004.22.90140.4540","doi":"https://doi.org/10.1200/jco.2004.22.90140.4540","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2004.22.90140.4540","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":1.0,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2227257921","https://openalex.org/W2005758390","https://openalex.org/W2104845282","https://openalex.org/W2241216819","https://openalex.org/W2341104972","https://openalex.org/W2202588822","https://openalex.org/W2088495337","https://openalex.org/W2240844634","https://openalex.org/W1833688292","https://openalex.org/W2011686032"],"abstract_inverted_index":{"4540":[0],"Background:":[1],"The":[2,14,48,135,201,272],"GC":[3,51,275],"combination":[4,49,133,273],"has":[5,35,42,54,311],"become":[6],"a":[7,29,61,148,165,315],"standard":[8,75,316],"of":[9,50,66,80,89,99,115,118,139,152,167,183,254,274,287,308],"care":[10],"for":[11,77,164,251],"advanced":[12,39,102,281],"TCC.":[13,103],"epidermal":[15],"growth":[16],"factor":[17],"receptor":[18],"(EGFR)":[19],"is":[20,26,265,278],"frequently":[21],"expressed":[22],"in":[23,38,96,234,280],"TCC":[24],"and":[25,52,94,124,214,229,237,276],"associated":[27,296],"with":[28,46,101,159,297],"poor":[30],"prognosis.":[31],"While":[32],"gefitinib":[33,53,95,160,175,277,288],"alone":[34],"minimal":[36],"activity":[37],"TCC,":[40,282],"C":[41,140],"demonstrated":[43],"pre-clinical":[44],"synergy":[45],"gefitinib.":[47],"been":[55],"shown":[56],"to":[57,69,74,85,263,302,324],"be":[58,70,290],"safe.":[59],"Because":[60],"fixed":[62,91,149,304],"dose":[63,150,305],"rate":[64,151,306],"infusion":[65,307],"G":[67,93,143,317],"appears":[68],"more":[71],"effective":[72],"compared":[73],"dosing":[76,318],"the":[78,87,97,189,284,303],"treatment":[79,98,136],"pancreatic":[81],"cancer,":[82],"we":[83],"sought":[84],"test":[86],"efficacy":[88],"C,":[90],"dose-rate":[92],"patients":[100,106,185,241,246],"Methods:":[104],"Eligible":[105],"had":[107],"measurable":[108],"N2,":[109],"N3":[110],"or":[111],"M1":[112],"disease;":[113],"PS":[114],"0\u20132;":[116],"CrCl":[117],">":[119],"50":[120,255],"ml/min;":[121],"adequate":[122],"hematologic":[123],"liver":[125],"function;":[126],"no":[127,130],"brain":[128],"metastases;":[129],"prior":[131],"systemic":[132],"chemotherapy.":[134],"regimen":[137,294],"consisted":[138],"70mg/m2":[141],"D1,":[142],"1000mg/m2":[144],"D1+8":[145],"administered":[146],"at":[147],"10":[153],"mg/m2/min":[154],"every":[155],"3":[156,215,227],"weeks":[157],"concurrent":[158],"500":[161,176],"mg/day":[162,177],"PO":[163],"maximum":[166],"6":[168],"cycles.":[169],"Responders":[170],"were":[171,186,205,232,248],"continued":[172,313],"on":[173],"maintenance":[174],"until":[178],"progression.":[179],"Results:":[180],"A":[181],"total":[182],"27":[184],"accrued":[187],"before":[188],"study":[190],"was":[191,295],"halted":[192],"because":[193],"dose-limiting":[194],"toxicity":[195],"(DLT)":[196],"exceeded":[197],"pre-established":[198],"stopping":[199],"rules.":[200],"DLT":[202],"events":[203],"observed":[204,233],"2":[206,235],"Gr":[207,216],"5":[208],"(1":[209,220],"neutropenic":[210],"infection,":[211],"1":[212,222,224],"CVA)":[213],"4":[217,238],"non-hematologic":[218],"toxicities":[219],"hyperuricemia,":[221],"fatigue,":[223],"dyspnea).":[225],"Grade":[226],"diarrhea":[228],"skin":[230],"rash":[231],"(8%)":[236],"(16":[239],"%)":[240],"respectively.":[242],"Of":[243],"24":[244],"evaluable":[245],"there":[247],"12":[249],"responses":[250],"an":[252],"ORR":[253],"%":[256],"(95%":[257,268],"CI=":[258],"29":[259],"\u201371%).":[260],"Median":[261],"time":[262],"progression":[264],"6.9":[266],"months":[267],"CI:":[269],"3.8\u20138.9).":[270],"Conclusions:":[271],"active":[279],"although":[283],"relative":[285],"contribution":[286],"cannot":[289],"determined.":[291],"However,":[292],"this":[293],"excessive":[298],"toxicity,":[299],"possibly":[300],"due":[301],"G.":[309],"Accrual":[310],"therefore":[312],"employing":[314],"schedule.":[319],"No":[320],"significant":[321],"financial":[322],"relationships":[323],"disclose.":[325]},"counts_by_year":[{"year":2023,"cited_by_count":1}],"updated_date":"2026-10-12T09:40:04.860316","created_date":"2017-04-14T00:00:00"}